MediciNova, Inc

MNOVNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

49.2M

on 2026-06-30, from 49.0M on 2024-03-31 10-Q ↗

Newest

$300.0M

S-3 of 2025-12-05. 1 prospectus supplement filed under it since. S-3 ↗

$50.0M

Lucid Capital Markets, agreement of 2025-12-30. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗

Warrants

The 10-Q filed 2026-08-13 is not read yet.

Cash

11.2 quarters

$25.4M on 2026-06-30 ÷ $2.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 1 of its filings are not read yet.